Quick Takeaways
- Slate Path Capital LP has 1 issuer position tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Slate Path Capital LP
- Location
- New York, NY
- Signature
- Slate Path Capital LP, By: Jades GP, LLC, its General Partner, By: /s/ John Metzner, its Chief Operating Officer
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Slate Path Capital LP and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Cyclerion Therapeutics, Inc. ($0).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Slate Path Capital LP
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CYCN | Cyclerion Therapeutics, Inc. | 10%+ Owner | $0 | 21 Nov 2024 |
Insider Transactions Reported by Slate Path Capital LP:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.